Tianshu Pharmaceutical Awarded "Xiangyang 2022-2023 'Contract-Abiding and Credit-Worthy Enterprise'" Honorary Title

On June 21, 2024, Xiangyang Municipal Administration for Market Regulation announced the list of "Xiangyang 2022-2023 'Contract-Abiding and Credit-Worthy Enterprises'". Hubei Tianshu Pharmaceutical Co., Ltd. (Tianshu Pharmaceutical) was successfully awarded this title by virtue of its good social credit and standardized contract management system.

　　For a long time, Tianshu Pharmaceutical has attached great importance to the construction of the integrity system, always adhering to the integrity management concept of "win-win cooperation", regarding integrity management as the foundation of the enterprise's establishment and development, continuously improving the contract management system and earnestly fulfilling contract obligations. The award of the title of Xiangyang 2022-2023 "Contract-Abiding and Credit-Worthy Enterprise" is a comprehensive reflection of Tianshu Pharmaceutical's sound enterprise qualifications, good social reputation and standardized contract management. It demonstrates Tianshu Pharmaceutical's good image of valuing credit and helps the company further enhance its market competitiveness and promote the enterprise to become more stable, stronger and better.

　　In the future, Tianshu Pharmaceutical will continue to adhere to the business philosophy of honesty and trustworthiness, strengthen enterprise contract management, sign contracts in accordance with the law, and fulfill contracts with integrity; continue to seize market opportunities, continuously optimize the business structure, and promote standardized management.